Clare Selden
Founder, CSO, Director of Hepatican Ltd
Hepatican Ltd
London, United Kingdom
United Kingdom
Hepatican Ltd, a new SME, aims to make a transformative change to the lives of patients with liver failure, with a combined cell therapy/medical device.
My organisation
Hepatican Ltd is exploiting academic research and early development, to produce a bedside treatment for liver failure that will reduce the need for liver transplant, making better use of scarce available donor organs. Its IP offering is considerable. Its first aim is to raise investment to enable a first-in-human clinical trial for safety, with an indication of efficacy.
About me
My organisation
Hepatican Ltd
Hepatican Ltd is exploiting academic research and early development, to produce a bedside treatment for liver failure that will reduce the need for liver transplant, making better use of scarce available donor organs. Its IP offering is considerable. Its first aim is to raise investment to enable a first-in-human clinical trial for safety, with an indication of efficacy.